BFM
KALA icon

Boothbay Fund Management’s KALA BIO KALA Stock Holding History

Boothbay Fund Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4
Closed -$68K – 1660
2020
Q4 		$68K Sell
4
-17
-81% -$320K ﹤0.01% 1189
2020
Q3 		$389K Buy
+21
New +$483K 0.02% 733
2020
Q2 		– Sell
-33
Closed -$714K – 1042
2020
Q1 		$714K Sell
33
-35
-51% -$559K 0.06% 376
2019
Q4 		$623K Hold
68
– – 0.05% 432
2019
Q3 		$642K Buy
+68
New +$828K 0.06% 406

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's KALA Position: Q1 2021 in Review

Boothbay Fund Management sold out of KALA BIO (KALA) in Q1 2021, closing a stake of 4 shares — an estimated $68K sold.

Boothbay Fund Management first reported a position in KALA in Q3 2019 and held it in 5 quarters. The position peaked at $714K in Q1 2020. 106 funds tracked by Wall St. Rank hold KALA as of Q1 2021.

  • Boothbay Fund Management reported no remaining KALA BIO position as of Q1 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 4 KALA BIO shares in Q1 2021, an estimated $68K.
  • Boothbay Fund Management first reported a position in KALA BIO in Q3 2019 and held it in 5 quarters.
  • Boothbay Fund Management's KALA BIO position peaked at $714K in Q1 2020.
  • 106 funds tracked by Wall St. Rank held KALA BIO as of Q1 2021.

Based on Boothbay Fund Management's 13F filing for Q1 2021, filed 17 May 2021.